Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Palermo – page 7

389 clinical trials in Palermo, Italy across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Palermo at a glance
389
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

389 trials in Palermo

Open in trial search

Prostate cancer

Recruiting

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB

A Study of ADX-324 to Prevent Attacks in Patients With Hereditary Angioedema

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:ADX-324
  • Sponsor:Adarx Pharmaceuticals Inc.

Study of toripalimab, cisplatin and gemcitabine combination as first treatment for patients with recurrent or metastatic nasopharyngeal cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Humanitas Mirasole S.p.A.

A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:LTP001
  • Sponsor:Novartis Pharma AG

Study comparing daratumumab, lenalidomide and dexamethasone followed by linvoseltamab versus continued initial treatment in newly diagnosed multiple myeloma patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Daratumumab
  • Sponsor:Emn Trial Office S.r.l. Impresa Sociale

Study of RSV vaccine immune response persistence and revaccination safety in adult lung and kidney transplant recipients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:GSKVx000000017064
  • Sponsor:GlaxoSmithKline Biologicals

Study of ficerafusp alfa and pembrolizumab as first treatment for patients with PD-L1-positive recurrent or metastatic head and neck cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Ficerafusp alfa
  • Sponsor:Bicara Therapeutics Inc.

Study of Mitazalimab Injection Treatment for Patients with High-Risk Oral Potentially Malignant Disorders

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Mitazalimab
  • Sponsor:Humanitas Mirasole S.p.A.

Study of gilteritinib with fludarabine, cytarabine and idarubicin combination therapy in newly diagnosed FLT3-positive acute myeloid leukemia patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Gilteritinib
  • Sponsor:Fondazione G.I.M.Em.A Franco Mandelli Ets

Bacteraemia

Recruiting

Comparing piperacillin-tazobactam and meropenem for treating bloodstream infections caused by cephalosporin-resistant bacteria in adult patients

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Meropenem Anhydrous
  • Sponsor:Azienda Ospedaliero Universitaria Di Modena

Study of Rilvegostomig with Bevacizumab and Tremelimumab as First-line Treatment for Patients with Advanced Liver Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:AstraZeneca AB

Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Rilzabrutinib
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Palermo

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on metastatic colorectal cancer treatments and novel approaches for multiple myeloma. Studies are evaluating targeted therapies for diffuse large B-cell lymphoma and investigating new treatment combinations for various cancer types.

  • Colorectal Cancer Treatment Strategies
  • Lymphoma Therapy Development
  • Multiple Myeloma Management

Advanced research includes evaluation of targeted therapies and immunotherapy combinations.

02 Cardiovascular Studies

Comprehensive research into heart failure prevention and cardiovascular disease management. Clinical trials are examining new therapeutic approaches for pulmonary arterial hypertension and innovative treatments for cardiovascular complications.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Hypertension Treatment

Focus on developing preventive strategies and novel therapeutic interventions.

03 Autoimmune Disorders

Groundbreaking research investigating treatments for multiple sclerosis and systemic sclerosis. Studies evaluate new biological therapies and innovative approaches for managing autoimmune conditions including psoriatic arthritis.

  • Multiple Sclerosis Therapies
  • Inflammatory Disease Management
  • Autoimmune Treatment Innovation

Emphasis on developing targeted therapies for various autoimmune conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.